|
|
|
|
|
|
|
|
Secure, sustainable raw material supply is at the core of every biopharmaceutical innovation. Breakthrough therapies leveraging cell culture media depends on quality products, and companies rely on strong supplier relationships to compete in the industry. Nu-Tek BioSciences meets your supply and sustainability needs with our state-of-the-art facility and 100% animal-free products. Improve your cell culture titer and simplify your supply without compromising on quality and environmental impact. Contact us today.
|
|
|
|
|
|
|
|
By Matthias Gerlach, Ph.D., independent executive advisor in pharma and biotech
|
Some of the most useful information relevant to CDMO selection is also the hardest to obtain. Here are suggestions for uncovering data that tells the whole capability story.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
When To Conduct GMP Versus Non-GMP Stability Studies
|
|
Article | By Bodo Brocks and Andrea Hawe, Coriolis Pharma
|
Understanding when to leverage GMP vs non-GMP stability studies and where each approach delivers maximum value can help sponsors make better development decisions and reach clinic faster.
|
|
|
|
|
|
Redefining CAR-T Speed And Strength: A Conversation
|
|
Q&A | Resilience
|
Uncover how an autologous CAR-T platform is addressing challenges in cell therapy manufacturing. A three-day process shortens cycles, improves T-cell potency and durability, and reduces costs.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
|
